In Vitro Diagnostics Business Outlook, Volume 3, Issue 1 - Focus on Molecular HLA Testing
24 Jan 2024
In Vitro Diagnostics Business Outlook is a bimonthly publication with six issues annually.
In Vitro Diagnostics Business Outlook offers information and data that you cannot get anywhere else, including:
- Market data and forecasts (growth rates, market size, market share, etc.) to identify growth opportunities
- A comprehensive view of the IVD market with test categories covered and company briefs
- M&A activities, selected partnerships & collaborations, partnership deals, and more
- Industry & region watch to help tailor strategies
- Analysis of news and events and reporting on news not easily available
Table of Contents
-
Market Analysis: Molecular HLA/Transplant Testing
- Overview of Molecular HLA/Transplant Testing
- Market Outlook
- Regional Market
-
Top Company Briefs
- Immucor
- Luminex/DiaSorin
- CareDx
- Thermo Fisher Scientific
-
Executive News Briefing
- DEKFI Diagnostics Appoint New CEO
- Onera Raises $32 Million in Funding
- Cleveland Diagnostics Completes $75 Million in Funding
-
Financial Highlights: Agilent and Hologic
- Agilent Full Year Fiscal 2023 Sales up 1.5% in Core Business YOY
- Hologic Supports Strong Financial Performance in Full-Year Fiscal Year Guidance
-
Diagnostic Market Mergers, Acquisitions and Partnership Deals
- Mergers and Acquisitions
- Partnerships and Collaborations
-
Industry Watch
- COVID-19 Update
-
Region Watch
- Saudi Arabia
-
Broad-based Company Announcements
- QuidelOrtho Obtains FDA Nod
- Illumina Plans to Divest Grail
- Roche to Acquire LumiraDx
- QIAGEN Expands Footprint with New Regional Headquarters in Middle East